A Phase II Clinical Study of Cadonilimab in Treatment-naïve or Relapsed Extensive Small Cell Lung Cancer

NCT06406673 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

70

Enrollment

OTHER_GOV

Sponsor class

Conditions

Extensive Small Cell Lung Cancer

Interventions

DRUG: Cadonilimab+EC/ET+RT
DRUG: Cadonilimab+vorolanib

Sponsor

Henan Cancer Hospital